VIYA Health, the exclusive distributor of Incepta Pharmaceutical’s WHO PreQualified Family Planning solution, DMPA SC, in Nigeria, had strategic discussions with the Oyo State Primary Healthcare Board to expand access to quality, affordable family planning services across the State.
The stakeholder engagement session was held at the State Secretariat, Agodi, Ibadan.
The meeting focused on expanding access to Medogen SubQ, a World Health Organization prequalified (WHO PQ) Family Planning product produced by Incepta Pharmaceuticals. Medogen SubQ’s WHO prequalification demonstrates quality assurance signaling adherence with stringent international standards, strengthening credibility and reputation, thus, providing healthcare providers and women with a safe, effective and affordable contraceptive option that meets internationally recognised standards.
Speaking at the event Muideen Olatunji, Physician and Executive Secretary, Oyo State Primary Healthcare Board, welcomed the engagement and acknowledged the State’s long-standing openness to family planning initiatives and innovative programmes.
He reiterated the State’s commitment to investing in health
This post was originally published on this site.
